FDA Approved: GRALISE — Supplemental Application (Almatica Pharma LLC)

View source ↗

Summary

FDA approved a supplemental application for GRALISE (gabapentin) submitted by Almatica Pharma LLC, resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• GRALISE (gabapentin)

Snippet

SUPPL AP for GRALISE (GABAPENTIN)